Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy.

Presicce P, Orsborn K, King E, Pratt J, Fichtenbaum CJ, Chougnet CA.

PLoS One. 2011;6(12):e28118. doi: 10.1371/journal.pone.0028118. Epub 2011 Dec 5.

2.
3.

Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment.

Rueda CM, Velilla PA, Chougnet CA, Rugeles MT.

PLoS One. 2013 Aug 15;8(8):e71062. doi: 10.1371/journal.pone.0071062. eCollection 2013.

4.

Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Schulze Zur Wiesch J, Thomssen A, Hartjen P, Tóth I, Lehmann C, Meyer-Olson D, Colberg K, Frerk S, Babikir D, Schmiedel S, Degen O, Mauss S, Rockstroh J, Staszewski S, Khaykin P, Strasak A, Lohse AW, Fätkenheuer G, Hauber J, van Lunzen J.

J Virol. 2011 Feb;85(3):1287-97. doi: 10.1128/JVI.01758-10. Epub 2010 Nov 3.

5.

Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.

Méndez-Lagares G, Pozo-Balado MM, Genebat M, García Pergañeda A, Leal M, Pacheco YM.

J Infect Dis. 2012 May 15;205(10):1501-9. doi: 10.1093/infdis/jis230. Epub 2012 Mar 28. Erratum in: J Infect Dis. 2012 Dec 15;206(12):1951. del Mar del Pozo Balado, María [corrected to Pozo-Balado, María M]; Genebat González, Miguel [corrected to Genebat, Miguel]; García Pergañeda Sánchez, Antonio [corrected to García-Pergañeda, Antonio]; Leal Noval, Manuel [corrected to Leal, Manuel]; Pacheco López, Yolanda María [corrected to Pacheco, Yolanda María].

6.

HCV coinfection does not alter the frequency of regulatory T cells or CD8+ T cell immune activation in chronically infected HIV+ Chinese subjects.

Zhuang Y, Wei X, Li Y, Zhao K, Zhang J, Kang W, Sun Y.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1044-51. doi: 10.1089/AID.2011.0318. Epub 2012 Mar 2.

PMID:
22214236
7.

HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.

Rueda CM, Velilla PA, Chougnet CA, Montoya CJ, Rugeles MT.

PLoS One. 2012;7(1):e30307. doi: 10.1371/journal.pone.0030307. Epub 2012 Jan 19.

8.

Thymic function in HIV-infection.

Kolte L.

Dan Med J. 2013 Apr;60(4):B4622. Review.

PMID:
23651726
9.

Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.

Horta A, Nobrega C, Amorim-Machado P, Coutinho-Teixeira V, Barreira-Silva P, Boavida S, Costa P, Sarmento-Castro R, Castro AG, Correia-Neves M.

PLoS One. 2013;8(2):e57336. doi: 10.1371/journal.pone.0057336. Epub 2013 Feb 20.

10.

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.

Lim A, French MA, Price P.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):248-57. doi: 10.1097/QAI.0b013e3181a74fad.

PMID:
19363449
11.

Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.

Tang Y, Jiang L, Zheng Y, Ni B, Wu Y.

BMC Immunol. 2012 Apr 11;13:17. doi: 10.1186/1471-2172-13-17.

13.

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.

Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D, Clerici M.

Blood. 2011 Sep 22;118(12):3263-72. doi: 10.1182/blood-2011-01-329060. Epub 2011 May 16.

14.

Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.

Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.

Int Immunopharmacol. 2009 Jul;9(7-8):831-6. doi: 10.1016/j.intimp.2009.03.009. Epub 2009 Mar 18.

PMID:
19303058
15.

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.

16.

Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.

Weiss L, Piketty C, Assoumou L, Didier C, Caccavelli L, Donkova-Petrini V, Levy Y, Girard PM, Burgard M, Viard JP, Rouzioux C, Costagliola D; ANRS 116 SALTO study group.

PLoS One. 2010 Jul 21;5(7):e11659. doi: 10.1371/journal.pone.0011659.

17.

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.

Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81.

PMID:
15764953
18.

Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity.

Angin M, Klarenbeek PL, King M, Sharma SM, Moodley ES, Rezai A, Piechocka-Trocha A, Toth I, Chan AT, Goulder PJ, Ndung'u T, Kwon DS, Addo MM.

PLoS One. 2014 Feb 3;9(2):e86920. doi: 10.1371/journal.pone.0086920. eCollection 2014.

19.
20.

Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts.

Zhou H, Zhao H, Hao Y, Song C, Han J, Zhang J, Gao G, Han N, Yang D, Li Y, Zhang F, Zeng H.

AIDS. 2013 Apr 24;27(7):1059-69. doi: 10.1097/QAD.0b013e32835e2b99.

PMID:
23299175
Items per page

Supplemental Content

Write to the Help Desk